Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

Terns Pharmaceuticals (TERN) Non Operating Income (2020 - 2022)

Terns Pharmaceuticals' Non Operating Income history spans 3 years, with the latest figure at -$786000.0 for Q4 2022.

  • For Q4 2022, Non Operating Income fell 7960.0% year-over-year to -$786000.0; the TTM value through Dec 2022 reached -$351000.0, down 977.5%, while the annual FY2025 figure was $14.5 million, 9.19% up from the prior year.
  • Non Operating Income reached -$786000.0 in Q4 2022 per TERN's latest filing, down from $485000.0 in the prior quarter.
  • In the past five years, Non Operating Income ranged from a high of $485000.0 in Q3 2022 to a low of -$2.8 million in Q4 2020.
  • Average Non Operating Income over 3 years is -$249333.3, with a median of $4000.0 recorded in 2021.
  • The largest YoY upside for Non Operating Income was 12025.0% in 2022 against a maximum downside of 7960.0% in 2022.
  • A 3-year view of Non Operating Income shows it stood at -$2.8 million in 2020, then soared by 100.36% to $10000.0 in 2021, then tumbled by 7960.0% to -$786000.0 in 2022.
  • Per Business Quant, the three most recent readings for TERN's Non Operating Income are -$786000.0 (Q4 2022), $485000.0 (Q3 2022), and -$54000.0 (Q2 2022).